Transforming drug delivery platform for bone cancer

Our Technology

We incorporate approved tumor killing molecules with high accretion to nano and micro particles of the bone minerals i.e., Hydroxyapatite (HA). In addition, a systemic loading of a specific drug will seek, bind, and exert a local biological effect. This increases the efficacy of targeted drug delivery without causing side-effects in other tissues.

Current Research Areas

Spatio-temporal controlled local delivery of various first-line anti-cancer agents

Explore the interactions between anti-cancer agents and hydroxyapatite to screen for more HA binding drugs

Explore intracellular delivery of anti-cancer agents by nano-materials to boost its efficacy